Fig. 4From: How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?Responses to question: ‘Have you been involved with any Europe’s Beating Cancer Plan Initiatives?’. Industry response not shown: Responses suggested that HTA divisions within the industry are not involved in the EBCP but oncology and health policy devisions are involved (personal communication)Back to article page